Table 3 Seroprevalence of HBV and vaccination coverage in the two regions.
| Â | Number in methadone care N | HBV screening coverage N (%) | HBV prevalence anti-HBc N (%) | HBV vaccination coverage N (%) |
|---|---|---|---|---|
Amsterdam* | 2024 | 680 (34%) | 225 (33%) | 1469 (92%)*** |
Heerlen** | 287 | 197 (69%) | 93 (48%) | 130 (45%) |